Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objectives: This study aimed to identify the current patterns of cancer incidence and estimate the projected cancer incidence and mortality between 2020 and 2035 in Korea. Methods: Data on cancer incidence cases were extracted from the Korean Statistical Information Service from 2000 to 2017, and data on cancer-related deaths were extracted from the National Cancer Center from 2000 to 2018. Cancer cases and deaths were classified according to the International Classification of Diseases, 10th edition. For the current patterns of cancer incidence, age-standardized incidence rates (ASIRs) and age-standardized mortality rates were investigated using the 2000 mid-year estimated population aged over 20 years and older. A joinpoint regression model was used to determine the 2020 to 2035 trends in cancer. Results: Overall, cancer cases were predicted to increase from 265 299 in 2020 to 474 085 in 2035 (growth rate: 1.8%). The greatest increase in the ASIR was projected for prostate cancer among male (7.84 vs. 189.53 per 100 000 people) and breast cancer among female (34.17 vs. 238.45 per 100 000 people) from 2000 to 2035. Overall cancer deaths were projected to increase from 81 717 in 2020 to 95 845 in 2035 (average annual growth rate: 1.2%). Although most cancer mortality rates were projected to decrease, those of breast, pancreatic, and ovarian cancer among female were projected to increase until 2035. Conclusions: These up-to-date projections of cancer incidence and mortality in the Korean population may be a significant resource for implementing cancer-related regulations or developing cancer treatments.
Abstract
Objectives: This study aimed to identify the current patterns of cancer incidence and estimate the projected cancer incidence and mortality between 2020 and 2035 in Korea. Methods: Data on cancer incidence cases were extracted from the Korean Statistical Information Service from 2000 to 2017, and data on cancer-related deaths were extracted from the National Cancer Center from 2000 to 2018. Cancer cases and deaths were classified according to the International Classification of Diseases, 10th edition. For the current patterns of cancer incidence, age-standardized incidence rates (ASIRs) and age-standardized mortality rates were investigated using the 2000 mid-year estimated population aged over 20 years and older. A joinpoint regression model was used to determine the 2020 to 2035 trends in cancer. Results: Overall, cancer cases were predicted to increase from 265 299 in 2020 to 474 085 in 2035 (growth rate: 1.8%). The greatest increase in the ASIR was projected for prostate cancer among male (7.84 vs. 189.53 per 100 000 people) and breast cancer among female (34.17 vs. 238.45 per 100 000 people) from 2000 to 2035. Overall cancer deaths were projected to increase from 81 717 in 2020 to 95 845 in 2035 (average annual growth rate: 1.2%). Although most cancer mortality rates were projected to decrease, those of breast, pancreatic, and ovarian cancer among female were projected to increase until 2035. Conclusions: These up-to-date projections of cancer incidence and mortality in the Korean population may be a significant resource for implementing cancer-related regulations or developing cancer treatments.
참고문헌 (31)
- Sung H, "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71(3), pp.209~249 (2021)
- "Global health estimates 2020: deaths by cause, age, sex, by country and by region, 2000-2019"[URL]
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016", Cancer Research and Treatment, 51(2), pp.417~430 (2019), 대한암학회
- Jung Yoon-Sun, "Measuring the Burden of Disease in Korea, 2008-2018", 예방의학회지, 54(5), pp.293~300 (2021), 대한예방의학회[DOI]
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2020", Cancer Research and Treatment, 52(2), pp.351~358 (2020), 대한암학회
- 권순석, "Updates on cancer epidemiology in Korea, 2018", 전남의대학술지, 54(2), pp.90~100 (2018), 의과학연구소[DOI]
- Quante AS, "Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030", Cancer Med, 5(9), pp.2649~2656 (2016)
- Kim KW, "Super aging in South Korea unstoppable but mitigatable : a sub-national scale population projection for best policy planning", Spat Demogr, 8(2), pp.155~173 (2020)
- Kim HJ, "Permutation tests for joinpoint regression with applications to cancer rates", Stat Med, 19(3), pp.335~351 (2000)
- "Joinpoint trend analysis software" (2022)[URL]
- "Average annual percent change(AAPC) and confidence interval"[URL]
- Rahib L, "Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States", Cancer Res, 74(11), pp.2913~2921 (2014)
- 고영휘, "Influence of repeated prostate-specific antigen screening on treatment pattern in a country with a limited social perception of prostate cancer: Korean national wide observational study", Investigative and Clinical Urology, 62(3), pp.282~289 (2021), 대한비뇨의학회[DOI]
- Han HH, "Epidemiology of prostate cancer in South Korea", Prostate Int, 3(3), pp.99~102 (2015)
- Hanf V, "Reproduction and breast cancer risk", Breast Care(Basel), 9(6), pp.398~405 (2014)
- Collaborative Group on Hormonal Factors in Breast Cancer, "Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease", Lancet, 360(9328), pp.187~195 (2002)
- Collaborative Group on Hormonal Factors in Breast Cancer, "Breast cancer and hormonal contraceptives : collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies", Lancet, 347(9017), pp.1713~1727 (1996)
- Collaborative Group on Hormonal Factors in Breast Cancer, "Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108,411 women without breast cancer", Lancet, 350(9084), pp.1047~1059 (1997)
- Collaborative Group on Hormonal Factors in Breast Cancer, "Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies", Lancet Oncol, 13(11), pp.1141~1151 (2012)
- 박수경, "한국인에서 유방암의 역학적 특성", 대한의사협회지, 62(8), pp.424~436 (2019), 대한의사협회
- Choi E, "Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality", NPJ Breast Cancer, 7(1), pp.83~ (2021)
- Shin DW, "Conditional relative survival of ovarian cancer : a Korean national cancer registry study", Front Oncol, 11, pp.639839~ (2021)
- Lee JH, "Overdiagnosis and screening for thyroid cancer in Korea", Lancet, 384(9957), pp.1848~ (2014)
- Park SH, "A qualitative study of women’s views on overdiagnosis and screening for thyroid cancer in Korea", BMC Cancer, 15, pp.858~ (2015)
- Li M, "Global trends in thyroid cancer incidence and the impact of overdiagnosis", Lancet Diabetes Endocrinol, 8(6), pp.468~470 (2020)
- 지병훈, "한국인에서 신장암의 과잉 진단 및 작은 국소신장암에서 능동적 관찰의 의미", Journal of Urologic Oncology, 16(1), pp.15~24 (2018), 대한비뇨기종양학회[DOI]
- 변석수, "The establishment of KORCC (KOrean Renal Cell Carcinoma) database", Investigative and Clinical Urology, 57(1), pp.50~57 (2016), 대한비뇨의학회[DOI]
- "National cancer control programs in Korea", J Korean Med Sci, 22(Suppl), pp.S3~S4 (2007)
- Smittenaar CR, "Cancer incidence and mortality projections in the UK until 2035", Br J Cancer, 115(9), pp.1147~1155 (2016)
- Jürgens V, "A Bayesian generalized age-period-cohort power model for cancer projections", Stat Med, 33(26), pp.4627~4636 (2014)
- "nordpred: fit power 5 and poisson age-period-cohort models for.."[URL]